Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Transcript of Earnings conference call_Q3 FY 2022
February 24, 2022
Newspaper Publication_Unaudited Financial Results_December 31, 2021
February 15, 2022
Intimation - Rescheduling of Investor conference call_February 15, 2022
February 15, 2022
Postponement of Investor conference call_February 14, 2022
February 14, 2022
Outcome of Board Meeting_February 12, 2022
February 12, 2022
Intimation about Investor conference call_February 15, 2022
February 11, 2022
Intimation of Board Meeting_February 12, 2022
February 5, 2022
Reconciliation of Share Capital Audit_December 31, 2021
January 27, 2022
Certificate under Regulation 74(5)_December 31, 2021
January 5, 2022
Intimation of Closure of Trading Window_December 31, 2021
December 31, 2021
Corporate Governance Report_December 31, 2021
December 31, 2021
Review of Credit Rating for bank facilities_December 2021
December 25, 2021
Investor Presentation_December 23, 2021
December 23, 2021
Schedule of Investor Conference call_December 23, 2021
December 20, 2021
Approval of Scheme of Amalgamation and Arrangement_December 2021
December 16, 2021
Outcome of Voting on Postal Ballot_December 13, 2021
December 13, 2021
Previous
1
...
Next
18 / 36